Literature DB >> 6117199

Sulfasalazine hepatotoxicity.

J D Losek, S L Werlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6117199     DOI： 10.1001/archpedi.1981.02130350070025

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  7 in total

1.  Sulphasalazine hepatotoxicity after 15 years' successful treatment for ulcerative colitis.

Authors:  T W Lennard; J R Farndon
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-09

Review 2.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

3.  Acute sulphasalazine hepatotoxicity.

Authors:  P E Jennings; R L Blandford; F D Rosenthal
Journal:  Postgrad Med J       Date:  1986-04       Impact factor: 2.401

Review 4.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

Review 5.  Gastrointestinal and hepatic manifestations of rheumatoid arthritis.

Authors:  Ellen C Ebert; Klaus D Hagspiel
Journal:  Dig Dis Sci       Date:  2011-01-04       Impact factor: 3.487

6.  Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.

Authors:  L G Quallich; J Greenson; H M Haftel; R J Fontana
Journal:  BMC Gastroenterol       Date:  2001-08-29       Impact factor: 3.067

7.  Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity.

Authors:  Sean Hammond; Anna Olsson-Brown; Sophie Grice; Andrew Gibson; Joshua Gardner; Jose Luis Castrejón-Flores; Carol Jolly; Benjamin Alexis Fisher; Neil Steven; Catherine Betts; Munir Pirmohamed; Xiaoli Meng; Dean John Naisbitt
Journal:  Toxicol Sci       Date:  2022-02-28       Impact factor: 4.849
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.